ArticleReviews in cardiovascular medicine2026
Intra-Pancreatic Fat Deposition Versus Hepatic Fat in Relation to Incident Heart Failure: A Prospective Cohort Analysis.
Article in Reviews in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although liver fat has been extensively studied, its independent contribution to heart failure (HF) remains debated. Moreover, whether fat stored in different visceral organs confers comparable cardiovascular risk remains unclear. Therefore, this study aimed to examine the associations among intra-pancreatic fat deposition (IPFD), hepatic fat, and visceral adiposity and new-onset HF. Methods: This prospective analysis included 22,038 UK Biobank participants who were free of HF at baseline. Time-to-event associations of IPFD, liver fat, and total visceral fat volume with incident HF were estimated using Cox regression models. Results: Over a median follow-up of 13.6 years, 282 participants developed HF. Spline modeling suggested a monotonic increase in HF risk with higher IPFD, whereas liver fat showed a non-linear, inverted U-shaped pattern. In multivariable models adjusting for cardiometabolic risk factors, the highest IPFD tertile was associated with a greater risk of HF than the lowest tertile (hazard ratio [HR], 1.68; 95% confidence interval [CI], 1.15-2.46; Conclusions: Greater pancreatic fat accumulation was independently associated with future HF, regardless of established cardiometabolic risk factors. These results suggest that IPFD may provide additional value for HF risk assessment and prevention-oriented metabolic profiling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.